AAAAAA

   
Results: 1-11 |
Results: 11
Comparison of two dosages of tolcapone added to levodopa in nonfluctuatingpatients with PD
Authors: Suchowersky, O Bailey, P Pourcher, E Bulger, L Facciponte, G
Citation: O. Suchowersky et al., Comparison of two dosages of tolcapone added to levodopa in nonfluctuatingpatients with PD, CLIN NEUROP, 24(4), 2001, pp. 214-220
Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifussmuscular dystrophy
Authors: Brown, CA Lanning, RW McKinney, KQ Salvino, AR Cherniske, E Crowe, CA Darras, BT Gominak, S Greenberg, CR Grosmann, C Heydemann, P Mendell, JR Pober, BR Sasaki, T Shapiro, F Simpson, DA Suchowersky, O Spence, JE
Citation: Ca. Brown et al., Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifussmuscular dystrophy, AM J MED G, 102(4), 2001, pp. 359-367
Genome-wide scan for Parkinson's disease: The GenePD study
Authors: DeStefano, AL Golbe, LI Mark, MH Lazzarini, AM Maher, NE Saint-Hilaire, M Feldman, RG Guttman, M Watts, RL Suchowersky, O Lafontaine, AL Labelle, N Lew, MF Waters, CH Growdon, JH Singer, C Currie, LJ Wooten, GF Vieregge, P Pramstaller, PP Klein, C Hubble, JP Stacy, M Montgomery, E MacDonald, ME Gusella, JF Myers, RH
Citation: Al. Destefano et al., Genome-wide scan for Parkinson's disease: The GenePD study, NEUROLOGY, 57(6), 2001, pp. 1124-1126
A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease
Authors: Kieburtz, K Koroshetz, W McDermott, M Beal, MF Greenamyre, JT Ross, CA Shoulson, I Cudkowicz, ME Sexton, P Skeuse, C Rosas, D Jenkins, B Rosenblatt, A Sherr, M Hersch, S Cellar, J Guttman, M Brown, C Como, PG Marshall, F DeMarcaida, JA Zimmerman, C Marder, K Moskowitz, C Polanco, C Beltre, J Shannon, K Jaglin, JA Niederman, F Ashizawa, T Hunter, C Hunter, C Hauser, R Walker, A Gauger, L Hahn, MA Delgado, H Dawson, T Siemers, E Seeberger, L Dingmann, C Dubinsky, R Gray, C Weiner, WJ Rodriguez-Batemen, D Albin, RL Wernette, K Harrison, M Rost-Ruffner, E Paulsen, J Rodnitzky, RL Dobson, J Vining, L Suchowersky, O Pantella, C Saint-Hilaire, MH Furtado, J Martin, W Wieler, M Walker, F Hunt, V Raymond, L Almqvist, E Rubin, A Blair, B Marek, K Caplan, K Baker, D Brocht, A Casaceli, C Orme, C Rudolph, A Rumfola, L Schifitto, G Shinaman, A Sulimowicz, K Watts, A Eapen, S Zhang, L
Citation: K. Kieburtz et al., A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease, NEUROLOGY, 57(3), 2001, pp. 397-404
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
Authors: Shoulson, I Penney, J McDermott, M Kieburtz, K Schwid, SR Kayson, E Chase, T Fahn, S Greenamyre, JT Lang, A Siderowf, A Pearson, N Harrison, M Rost-Ruffner, E Colcher, A Lloyd, M Matthews, M Pahwa, R McGuire, D Lew, MF Schuman, S Marek, K Broshjeit, S Factor, S Brown, D Feigin, A Mazurkiewicz, J Ford, B Jennings, D Dillon, S Comella, C Blasucci, L Janko, K Shulman, L Wiener, W Bateman-Rodriguez, D Carrion, A Suchowersky, O Lafontaine, AL Pantella, C Siemers, E Belden, J Davies, R Lannon, M Grimes, D Gray, P Martin, W Kennedy, L Adler, C Newman, S Hammerstad, J Stone, C Lewitt, P Bardram, K Mistura, K Miyasaki, J Johnston, L Cha, JHJ Tennis, M Panisset, M Hall, J Tetrud, J Friedlander, J Hauser, R Gauger, L Rodnitzky, R Deleo, A Dobson, J Seeberger, L Dingmann, C Tarsy, D Ryan, P Elmer, L Ruzicka, D Stacy, M Brewer, M Locke, B Baker, D Casaceli, C Day, D Florack, M Hodgeman, K Laroia, N Nobel, R Orme, C Rexo, L Rothenburgh, K Sulimowicz, K Watts, A Wratni, E Tariot, P Cox, C Leventhal, C Alderfer, V Craun, AM Frey, J McCree, L McDermott, J Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease
Authors: Chong, DJ Suchowersky, O Szumlanski, C Weinshilboum, RM Brant, R Campbell, NRC
Citation: Dj. Chong et al., The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease, CLIN NEUROP, 23(3), 2000, pp. 143-148
A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study
Authors: Holloway, R Shoulson, I Fahn, S Kieburtz, K Lang, A Marek, K McDermott, M Seibyl, J Weiner, W Welsh, M Kamp, C Day, D Pahwa, R Smith, D McGuire, D Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Mistura, K Bloomfield, W Miyasaki, J Duff, J Sime, E Suchowersky, O Argatoff, P Andreas, Y Kurth, M Brewer, M Russell, D Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Beach, J Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajout, A Wilson, W McCullan, L Brown, K Clark, R Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Pfeiffer, R Rast, S Bujak, G Casaceli, C Freimuth, A Hodgeman, K Honsinger, K Watts, A Hall, WJ Leventhal, CM Reich, S Tariot, P Balgoyen, D Corak, D Corrigan, M Driver, M Fraser, TJ Lai, PY Gomez-Mancilla, B Munting, J Peters, G Rowland, C Sullivan, H Trasky, R Wright, G Berber, E Morris, J Mills, D Hallak, L Rines, S
Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Authors: Holloway, R Shoulson, I Kieburtz, K McDermott, M Tariot, P Kamp, C Day, D Shinaman, A Fahn, S Lang, A Marek, K Seibyl, J Weiner, W Welsh, M Pahwa, R Coe, S Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Miyasaki, J Duff, J Sime, E Suchowersky, O Stacy, M Kurth, M Brewer, M Harrigan, M Russell, DS Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Atassi, F Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajput, A Shirley, T Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Schuman, S Pfeiffer, R Rast, S Pfeiffer, B Brocht, A Casaceli, C Daigneault, S Hodgeman, K Honsinger, K O'Connell, C Watts, A
Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938
Management of Parkinson's disease - A review of current and new therapies
Authors: Mendis, T Suchowersky, O Lang, A Gauthier, S
Citation: T. Mendis et al., Management of Parkinson's disease - A review of current and new therapies, CAN J NEUR, 26(2), 1999, pp. 89-103
COMT inhibitors in Parkinson's disease
Authors: Rivest, J Barclay, CL Suchowersky, O
Citation: J. Rivest et al., COMT inhibitors in Parkinson's disease, CAN J NEUR, 26, 1999, pp. S34-S38
Parkinson's disease management: Towards a new paradigm
Authors: Guttman, M Suchowersky, O
Citation: M. Guttman et O. Suchowersky, Parkinson's disease management: Towards a new paradigm, CAN J NEUR, 26, 1999, pp. S53-S57
Risultati: 1-11 |